ALICE: a randomized placebo-controlled phase II study evaluating atezolizumab combined with immunogenic chemotherapy in patients with metastatic triple-negative breast cancer

被引：0
|
作者：
J. A. Kyte
A. Røssevold
R. S. Falk
B. Naume
机构：
[1] Oslo University Hospital,Department of Clinical Cancer Research
[2] Oslo University Hospital,Department of Cancer Immunology
[3] Oslo University Hospital,Department of Oncology
[4] Oslo University Hospital,Oslo Centre for Biostatistics and Epidemiology
[5] University of Oslo,Institute of Clinical Medicine
来源：
Journal of Translational Medicine | / 18卷
关键词：
Breast cancer; Triple negative; Immunotherapy; Checkpoint inhibitor; Immunogenic cell death; PD-1; PD-L1; Anthracycline; Cyclophosphamide;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Cabozantinib for metastatic breast carcinoma: results of a phase II placebo-controlled randomized discontinuation study
    Tolaney, Sara M.
    Nechushtan, Hovav
    Ron, Ilan-Gil
    Schoffski, Patrick
    Awada, Ahmad
    Yasenchak, Chris A.
    Laird, A. Douglas
    O'Keeffe, Bridget
    Shapiro, Geoffrey I.
    Winer, Eric P.
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 160 (02) : 305 - 312
  • [42] Cabozantinib for metastatic breast carcinoma: results of a phase II placebo-controlled randomized discontinuation study
    Sara M. Tolaney
    Hovav Nechushtan
    Ilan-Gil Ron
    Patrick Schöffski
    Ahmad Awada
    Chris A. Yasenchak
    A. Douglas Laird
    Bridget O’Keeffe
    Geoffrey I. Shapiro
    Eric P. Winer
    Breast Cancer Research and Treatment, 2016, 160 : 305 - 312
  • [43] Phase II study of camrelizumab plus chemotherapy as neoadjuvant therapy in patients with early triple-negative breast cancer
    Wang, Y.
    Liu, Y.
    Zhu, S.
    Bi, X.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S616 - S616
  • [44] A phase II study of nivolumab in combination with cabozantinib for metastatic triple-negative breast cancer (mTNBC)
    Barroso-Sousa, Romualdo
    Trippa, Lorenzo
    Li, Tianyu
    Keenan, Tanya E.
    Winship, Grace
    Andrews, Chelsea
    Osmani, Wafa
    Overmoyer, Beth
    Winer, Eric P.
    Mittendorf, Elizabeth A.
    Duda, Dan G.
    Tolaney, Sara M.
    CANCER RESEARCH, 2020, 80 (04)
  • [45] Nivolumab in combination with cabozantinib for metastatic triple-negative breast cancer: a phase II and biomarker study
    Romualdo Barroso-Sousa
    Tanya E. Keenan
    Tianyu Li
    Nabihah Tayob
    Lorenzo Trippa
    Ricardo G. Pastorello
    Edward T. Richardson III
    Deborah Dillon
    Zohreh Amoozgar
    Beth Overmoyer
    Stuart J. Schnitt
    Eric P. Winer
    Elizabeth A. Mittendorf
    Eliezer Van Allen
    Dan G. Duda
    Sara M. Tolaney
    npj Breast Cancer, 7
  • [46] Remarkable response to combined immunochemotherapy in patients with metastatic triple-negative breast cancer
    Philipovskiy, Alexander
    Chambers, Karinn
    Konstantinidis, Ioannis
    McCallum, Richard
    Corral, Javier
    Gaur, Sumit
    IMMUNOTHERAPY, 2020, 12 (18) : 1293 - 1302
  • [47] REMARKABLE RESPONSE TO COMBINED IMMUNOCHEMOTHERAPY IN PATIENTS WITH METASTATIC TRIPLE-NEGATIVE BREAST CANCER
    Ghafouri, S.
    Chambers, K.
    Konstantinidis, I.
    McCallum, R.
    Corral, J.
    Gaur, S.
    Philipovskiy, A.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2021, 69 (02) : 554 - 555
  • [48] Metronomic Chemotherapy for First-Line Treatment of Metastatic Triple-Negative Breast Cancer: A Phase II Trial
    Montagna, Emilia
    Bagnardi, Vincenzo
    Cancello, Giuseppe
    Sangalli, Claudia
    Pagan, Eleonora
    Iorfida, Monica
    Mazza, Manuelita
    Mazzarol, Giovanni
    Dellapasqua, Silvia
    Munzone, Elisabetta
    Goldhirsch, Aaron
    Colleoni, Marco
    BREAST CARE, 2018, 13 (03) : 177 - 181
  • [49] Atezolizumab Plus Chemotherapy vs. Chemotherapy in Advanced or Metastatic Triple-Negative Breast Cancer: A Cost-Effectiveness Analysis
    Liu, Xiaoyan
    Lang, Yitian
    Liao, Yahui
    Zhu, Yizhun
    FRONTIERS IN PUBLIC HEALTH, 2021, 9
  • [50] Phase I/II clinical trial of everolimus combined with gemcitabine/cisplatin for metastatic triple-negative breast cancer
    Park, In Hae
    Kong, Sun-Young
    Kwon, Youngmee
    Kim, Min Kyeong
    Sim, Sung Hoon
    Joo, Jungnam
    Lee, Keun Seok
    JOURNAL OF CANCER, 2018, 9 (07): : 1145 - 1151
12345